| pubmed-article:16815313 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16815313 | lifeskim:mentions | umls-concept:C0000956 | lld:lifeskim |
| pubmed-article:16815313 | lifeskim:mentions | umls-concept:C0001721 | lld:lifeskim |
| pubmed-article:16815313 | lifeskim:mentions | umls-concept:C0017431 | lld:lifeskim |
| pubmed-article:16815313 | lifeskim:mentions | umls-concept:C1704675 | lld:lifeskim |
| pubmed-article:16815313 | lifeskim:mentions | umls-concept:C0449438 | lld:lifeskim |
| pubmed-article:16815313 | lifeskim:mentions | umls-concept:C2917212 | lld:lifeskim |
| pubmed-article:16815313 | lifeskim:mentions | umls-concept:C1332829 | lld:lifeskim |
| pubmed-article:16815313 | lifeskim:mentions | umls-concept:C1428184 | lld:lifeskim |
| pubmed-article:16815313 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:16815313 | pubmed:dateCreated | 2006-7-3 | lld:pubmed |
| pubmed-article:16815313 | pubmed:abstractText | Our objective was to assess the effects of VKORC1 and CYP2C9 genotypes on severe overanticoagulation and time to achieve stability and their contributions to dose requirement during the initial phase of acenocoumarol treatment. | lld:pubmed |
| pubmed-article:16815313 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16815313 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16815313 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16815313 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:16815313 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16815313 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16815313 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16815313 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16815313 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16815313 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16815313 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16815313 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16815313 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:16815313 | pubmed:issn | 0009-9236 | lld:pubmed |
| pubmed-article:16815313 | pubmed:author | pubmed-author:EgbertsAntoin... | lld:pubmed |
| pubmed-article:16815313 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:16815313 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:16815313 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:16815313 | pubmed:author | pubmed-author:SchalekampTom... | lld:pubmed |
| pubmed-article:16815313 | pubmed:author | pubmed-author:RoijersJanine... | lld:pubmed |
| pubmed-article:16815313 | pubmed:author | pubmed-author:BrasséBjorn... | lld:pubmed |
| pubmed-article:16815313 | pubmed:author | pubmed-author:ChahidYoussef... | lld:pubmed |
| pubmed-article:16815313 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:16815313 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16815313 | pubmed:volume | 80 | lld:pubmed |
| pubmed-article:16815313 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16815313 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16815313 | pubmed:pagination | 13-22 | lld:pubmed |
| pubmed-article:16815313 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:16815313 | pubmed:meshHeading | pubmed-meshheading:16815313... | lld:pubmed |
| pubmed-article:16815313 | pubmed:meshHeading | pubmed-meshheading:16815313... | lld:pubmed |
| pubmed-article:16815313 | pubmed:meshHeading | pubmed-meshheading:16815313... | lld:pubmed |
| pubmed-article:16815313 | pubmed:meshHeading | pubmed-meshheading:16815313... | lld:pubmed |
| pubmed-article:16815313 | pubmed:meshHeading | pubmed-meshheading:16815313... | lld:pubmed |
| pubmed-article:16815313 | pubmed:meshHeading | pubmed-meshheading:16815313... | lld:pubmed |
| pubmed-article:16815313 | pubmed:meshHeading | pubmed-meshheading:16815313... | lld:pubmed |
| pubmed-article:16815313 | pubmed:meshHeading | pubmed-meshheading:16815313... | lld:pubmed |
| pubmed-article:16815313 | pubmed:meshHeading | pubmed-meshheading:16815313... | lld:pubmed |
| pubmed-article:16815313 | pubmed:meshHeading | pubmed-meshheading:16815313... | lld:pubmed |
| pubmed-article:16815313 | pubmed:meshHeading | pubmed-meshheading:16815313... | lld:pubmed |
| pubmed-article:16815313 | pubmed:meshHeading | pubmed-meshheading:16815313... | lld:pubmed |
| pubmed-article:16815313 | pubmed:meshHeading | pubmed-meshheading:16815313... | lld:pubmed |
| pubmed-article:16815313 | pubmed:meshHeading | pubmed-meshheading:16815313... | lld:pubmed |
| pubmed-article:16815313 | pubmed:meshHeading | pubmed-meshheading:16815313... | lld:pubmed |
| pubmed-article:16815313 | pubmed:meshHeading | pubmed-meshheading:16815313... | lld:pubmed |
| pubmed-article:16815313 | pubmed:meshHeading | pubmed-meshheading:16815313... | lld:pubmed |
| pubmed-article:16815313 | pubmed:meshHeading | pubmed-meshheading:16815313... | lld:pubmed |
| pubmed-article:16815313 | pubmed:meshHeading | pubmed-meshheading:16815313... | lld:pubmed |
| pubmed-article:16815313 | pubmed:meshHeading | pubmed-meshheading:16815313... | lld:pubmed |
| pubmed-article:16815313 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16815313 | pubmed:articleTitle | VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status: interaction between both genotypes affects overanticoagulation. | lld:pubmed |
| pubmed-article:16815313 | pubmed:affiliation | Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. t.schalekamp@pharm.uu.nl | lld:pubmed |
| pubmed-article:16815313 | pubmed:publicationType | Journal Article | lld:pubmed |
| entrez-gene:1559 | entrezgene:pubmed | pubmed-article:16815313 | lld:entrezgene |
| entrez-gene:79001 | entrezgene:pubmed | pubmed-article:16815313 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16815313 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16815313 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16815313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16815313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16815313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16815313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16815313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16815313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16815313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16815313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16815313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16815313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16815313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16815313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16815313 | lld:pubmed |
